Please use this identifier to cite or link to this item: https://dspace.ctu.edu.vn/jspui/handle/123456789/31865
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLe, Nhat Minh-
dc.contributor.authorVo, Trong Nhan-
dc.contributor.authorTran, Thu Huong-
dc.contributor.authorNguyên, Thi Nga-
dc.contributor.authorLe, Tri Vien-
dc.contributor.authorPhung, Thi Kim Huê-
dc.date.accessioned2020-08-19T03:14:57Z-
dc.date.available2020-08-19T03:14:57Z-
dc.date.issued2019-
dc.identifier.issn1811-4989-
dc.identifier.urihttps://dspace.ctu.edu.vn/jspui/handle/123456789/31865-
dc.description.abstractEfficient cancer treatment remains a huge challenge worldwide. As reported by the Worldly Health Organization, the number of cancer patients is estimated to be 24 million in 2035, which is a 70% increase compared to 14.1 million in 2012. The severity of cancer is duc to the presence of cancer stem cells (CSCs), which are directly related to drug resistance, metastasis, and tumor relapse.vi_VN
dc.language.isoenvi_VN
dc.relation.ispartofseriesTạp chí Công nghệ Sinh học;Số 17(03) .- Tr.435-440-
dc.subjectCancer stem cellsvi_VN
dc.subjectCD133 monoclonal antibodyvi_VN
dc.subjectET2-luminescent nano complexvi_VN
dc.subjectCCD-18COvi_VN
dc.subjectlon Tb³⁺vi_VN
dc.subjectNTERA-2vi_VN
dc.subjectMetastatic cancer cellsvi_VN
dc.titleLabeling efficiency of TB³⁺ conjugated CD133 monoclonal antibody nano complex targeting in vitro metastatic cancer cellsvi_VN
dc.typeArticlevi_VN
Appears in Collections:Công nghệ sinh học

Files in This Item:
File Description SizeFormat 
_file_
  Restricted Access
1.47 MBAdobe PDF
Your IP: 18.222.167.183


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.